Fundraising Fox
psigryph
Kitchener, CA · 1 known investors
Find your way into psigryph
Sign up to see every warm intro you have to psigryph
- Paths you didn't know you had: your email and LinkedIn already hold routes to the psigryph team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Psigryph develops nanoparticle and nanofibre platform technologies to deliver nutrients and insoluble drug molecules into cells, with applications ranging from cancer therapeutics to consumer dietary supplements. It also offers biofertilizers, biopesticides, and phytonutrient-based health products.
Founders & leadership
ST
Sean ThompsonCo-Founder, CEO and Board MemberSean Thompson held corporate development and clinical research roles at major pharmaceutical companies including GSK and Roche, where he led licensing and acquisition transactions, and later served as VP of Corporate Development at YM BioSciences (acquired by Gilead). He holds a B.Sc. from the University of Waterloo and is founder of Psigryph, which develops a plant-derived nanodelivery system for bioactive molecules.
TH
Tom HunterCo-founder
Investors · 1
Frequently asked questions
- What does psigryph do?
- Psigryph develops nanoparticle and nanofibre platform technologies to deliver nutrients and insoluble drug molecules into cells, with applications ranging from cancer therapeutics to consumer dietary supplements. It also offers biofertilizers, biopesticides, and phytonutrient-based health products.
- Who founded psigryph?
- psigryph was founded by Sean Thompson.
- Who are psigryph's investors?
- psigryph's investors include Foresight Canada.
- Where is psigryph headquartered?
- psigryph is headquartered in Kitchener, CA.